Argenx Se (ARGX) Profit After Tax (2016 - 2026)

Argenx Se (ARGX) posted Profit After Tax of $498.0 million for Q1 2026, up 23.48% on a QoQ basis from $403.3 million in Q4 2025, and up 111.59% year-over-year from $235.4 million in Q1 2025.

Argenx Se (ARGX) Profit After Tax (2016 - 2026) Analysis & Trends

Argenx Se's Profit After Tax history runs 11 years deep, the most recent figure standing at $498.0 million for Q1 2026.

  • Quarterly Profit After Tax rose 111.59% year-over-year to $498.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 billion (up 301.35% YoY) and the FY2025 annual result came in at $1.3 billion, up 55.1% from the prior year.
  • Profit After Tax was $498.0 million for Q1 2026 at Argenx Se, up from $403.3 million in the prior quarter.
  • Across five years, Profit After Tax topped out at $498.0 million in Q1 2026 and bottomed at -$674.2 million in Q2 2022.
  • A 5-year average of $109.0 million and a median of $83.9 million in 2024 frame the typical range for Profit After Tax.
  • Annual changes were most pronounced in 2022 — Profit After Tax sank 750.74% — and 2025, when it soared 2012.28%.
  • Argenx Se's Profit After Tax stood at $41.2 million in 2022, then soared by 48.35% to $61.2 million in 2023, then soared by 37.06% to $83.9 million in 2024, then surged by 380.97% to $403.3 million in 2025, then climbed by 23.48% to $498.0 million in 2026.
  • Business Quant data shows ARGX's Profit After Tax at $498.0 million in Q1 2026, $403.3 million in Q4 2025, and $386.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -36.84 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -14.46 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 227.36 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 1.03 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -65.60 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -26.94 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 498.00 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - -453.82 Mn
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 205.99 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 498.00 Mn
Dec 31, 2025 403.29 Mn
Sep 30, 2025 386.05 Mn
Jun 30, 2025 286.90 Mn
Mar 31, 2025 235.36 Mn
Dec 31, 2024 83.85 Mn
Sep 30, 2024 88.02 Mn
Jun 30, 2024 -15.00 Mn
Mar 31, 2024 -74.35 Mn
Dec 31, 2023 61.18 Mn
Sep 30, 2023 83.28 Mn
Jun 30, 2023 -83.86 Mn
Mar 31, 2023 76.18 Mn
Dec 31, 2022 41.24 Mn
Sep 30, 2022 241.02 Mn
Jun 30, 2022 -674.17 Mn
Mar 31, 2022 216.00 Mn
Dec 31, 2021 -244.88 Mn
Sep 30, 2021 230.87 Mn
Jun 30, 2021 103.60 Mn